{"id":"W2123808042","doi":"10.1200/jco.2009.23.2595","title":"Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":514,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genentech; Celgene; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Lomustine; Medicine; Internal medicine; Hazard ratio; Phases of clinical research; Adverse effect; Surgery; Progression-free survival; Gastroenterology; Toxicity; Chemotherapy; Confidence interval; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001135571,0.0009817128,0.001970496,0.0002784103,0.000233719,0.0006088217,0.0007825252,0.0007414946,0.00297529],"category_scores_gemma":[0.0008104638,0.0003313835,0.0009386296,0.0002971341,0.000570223,0.0004579618,0.0002001207,0.00198894,0.0004605458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007750638,"about_ca_system_score_gemma":0.001183106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009938764,"about_ca_topic_score_gemma":0.003811918,"domain_scores_codex":[0.9996276,0.0002352657,0.00002178257,0.0000393297,0.00002892643,0.00004705166],"domain_scores_gemma":[0.9994819,0.0001140558,0.0001754182,0.00003033549,0.00003049951,0.0001678739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8100671,0.03055096,0.004313426,0.001325364,0.002224862,0.0002020351,0.0001623952,0.002019233,0.03956105,0.0002700679,0.002351764,0.1069519],"study_design_scores_gemma":[0.5612321,0.4169405,0.01040616,0.00008284693,0.0008653785,0.0002897497,0.00005358512,0.001669907,0.00580948,0.0001663854,0.002449207,0.00003465299],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928522,0.00373953,0.0005184095,0.0003184674,0.0001216939,0.001030019,0.0003314766,0.00007228685,0.001016029],"genre_scores_gemma":[0.9919174,0.002791869,0.001381326,0.0005238077,0.0001307646,0.001116934,0.0007198552,0.00002293077,0.001395039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00297529,"threshold_uncertainty_score":0.00995332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0935028942315687,"score_gpt":0.4665395752541077,"score_spread":0.373036681022539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}